Identify, investigate, negotiate: How Singapore took steps to ensure access to Covid-19 vaccines
This was even though some solutions were as novel as the pathogen itself - some vaccine candidates were being developed with new technologies that have not been used in any other vaccines on the market. The data was limited, so risks had to be taken and bets made after careful analysis of available information. They all paid off on Monday night (Dec 21), when Singapore became the first nation in Asia to receive doses of the Pfizer-BioNTech Covid-19 vaccine. This, just weeks after Britain and the United States received theirs. Professor Benjamin Seet, who oversees the expert panel that provide...